CEO, Outcome Engenuity
David Marx is CEO of Outcome Engenuity, a Dallas-based risk management firm. David has a BS in Mechanical Systems Engineering (1985) and Juris Doctor in Law (1997). David’s firm currently spends the majority of its effort on helping high-consequence organizations develop values-supportive practices and culture.
David began his career as a Boeing aircraft design engineer. In his final years at Boeing, David organized a human factors and safety group. In his work at Boeing, David won the International Federation of Airworthiness’s Whittle Safety Award for his development of a human error investigation process used by airlines around the world.
In 1997, David launched a research and consulting practice focused on the management of human error through the integration of systems engineering, human factors, and the law. David has served as an advisor to the Federal Aviation Administration’s Human Factors Research Program and to the NASA Space Shuttle Program. David was the principal consultant to NASA in development of their major mishap investigation process, and he led an outside team to benchmark space shuttle processing quality. David has developed risk modeling methods, including an approach called socio- technical probabilistic risk assessment (ST-PRA), which has been used to model risk in aviation, space, rail, and healthcare.
In the healthcare sector, David has been working to help healthcare institutions and regulatory agencies reduce the risk of iatrogenic patient harm. In the area of system design, David’s ST-PRA process has been used to model and mitigate risks from wrong site surgery to medication errors. In the area of safety culture, David authored the document, “Patient Safety and the ‘Just Culture’: A Primer for Healthcare Executives,” for the National Institutes of Health. Widely seen as the father of “Just Culture,” David and his firm administer the Just Culture Community, a resource for organizations across industries who strive to create accountable, safety supportive cultures.
Dr. Martin Wale, BMBS, FRCPath, MBA, CCPE
Deputy Chief Medical Officer and Executive Medical Director, Medical Affairs and Research, Island Health
Martin was recruited to Vancouver Island Health Authority from the UK in July 2009, initially as Executive Medical Director for Quality, Research and Safety, and latterly as Deputy Chief Medical Officer and Executive Medical Director for Medical Affairs & Research.
Martin is a UK-trained medical microbiologist and communicable disease specialist. Prior to coming to Canada, he was Regional Director at the Health Protection Agency, and co-creator of the Nottingham Institute of Population Health. He then moved to be Chief Medical Officer at a large multi-site Acute Trust in the NHS in England, and concurrently a Fellow of the NHS Institute for Innovation and Improvement, working on initiatives including the “Productives” series (e.g. The Productive Ward - Releasing Time to Care) and novel approaches to the management of Clostridium difficile. He has an Executive MBA with a focus on organizational learning, and has since become a Canadian Certified Physician Executive.
Since 2014 Martin has been seconded part-time to the BC Ministry of Health, to lead the BC Medical Quality Initiative (BC MQI). This comprises both administrative systems to improve credentialing & privileging, based on province-wide adoption of CACTUS software and 64 privileging dictionaries, alongside a cultural approach using social innovation methodology, working in the space between organizations to build trust in quality improvement, . He is Associate Professor at UBC and Adjunct Professor at both UVic and Royal Roads University. His interests are broad, ranging from organizational and health-system strategy to practical implementation of sustainable improvement. His main achievements for the BC MQI have included delivery and implementation of CACTUS and the dictionaries, and the Three Compartment Model for medical quality. In Island Health they have included development of the Risk-Based Model for Infection Prevention and Control, creation of the Combined Quality System, and leading the Vancouver Island Research Capacity Building initiative. Outside work, he is an enthusiastic kayaker and photographer.
Managing Director of Volvo Car of Canada
Alexander joined the Volvo Car Corporation in 2007 and most recently served as Controller Car Operations & Deputy CFO with Volvo Cars of North America. Previously, Alexander spent three years with Volvo Canada as the Controller, Vice President of Finance & CFO before moving to Volvo Cars of North America in 2011. Prior to joining Volvo, Alexander held several positions at Ford Motor Company in Eastern Europe and Canada in Manufacturing, Customer Service and Marketing & Sales.
“The Volvo brand is experiencing a reinvigoration thanks to award-winning product, expanding our manufacturing footprint to America and a dedication to advancements in safety, technology and design.” said Alexander Lvovich. “In Canada, I look forward to building the momentum surrounding the brand, as we continue to offer Canadians innovative product in the luxury segment.”
Dr. Drew Digney
Executive Medical Director (EMD), Island Health Geography 2
Dr. Drew Digney is the Executive Medical Director (EMD) for Island Health Geography 2, comprising the majority of services for the communities of Nanaimo, Parksville, Qualicum, Port Alberni, and the West Coast from Bamfield to Ahousat. He is also responsible for Island-wide planning for oversight of the renal services, oncology, emergency services and trauma programs.
Dr. Digney has been practicing medicine for over 20 years and began his career as a full service family practitioner in Prince George, BC, Canada. After being on-call for obstetrics for 7 years he decided to pursue his passion and received his specialty certification for Emergency Medicine in 1999. Dr. Digney has practiced full-time emergency medicine for the last 17 years in Nanaimo and served as Emergency Site Chief for 10 of those years and was able to take the department to a nationally recognized leader in innovations, resulting in some of the best access and throughput times in the country.
He has served on a number of hospital, provincial and volunteer boards and finds he has a penchant for making changes. In his capacity as Executive Medical Director for Portfolio 2, Dr. Digney wants to seize on the opportunity of having oversight for most of a patient’s experience with Island Health and hopes to create a more patient-centered, systematic approach to care with front-line ownership as a major driver for the transformation. Dr. Digney continues to challenge our ‘system’ to look at every aspect of the patient’s visit to ensure that it has a value to the patient and that our healthcare industry is able to provide the care our patients deserve.
HoloLens & Mixed Reality Lead, Microsoft Canada
Michael Thibodeau leads Windows Mixed Reality and HoloLens Marketing at Microsoft Canada. With a passion for cutting-edge technology, Michael’s mandate is to inspire and collaborate with customers, partners, disrupters and innovators across Canada to help them unlock their potential and transform their solutions with the power of mixed reality (AR, VR and MR) across HoloLens and OEM devices.
Widely valued for his passion, collaboration, and creative approach, Michael has held a variety of positions including business management, operations and marketing during his 6 year tenure at Microsoft Canada. He believes technology enhances the world and he is committed helping Canadian customers reimagine the future of their business and empowering them to achieve more.
Dr. Clifford Ko
Director of the Division of Research and Optimal Patient Care, American College of Surgeons
Dr. Clifford Ko is the Director of the Division of Research and Optimal Patient Care at the American College of Surgeons. He oversees all the quality improvement programs, including the Bariatric Surgery Accreditation Program, the Cancer Accreditation program, the Trauma Verification program, the Surgeon Specific Registry, the Pediatric Surgery Verification Program, and the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). He also serves as the Director of ACS NSQIP, which recently was recognized with the Eisenberg Award from the National Quality Forum/Joint Commission.
Dr. Ko’s work focuses on surgical quality of care, including quality measurement, process improvement, value based care, and achieving high reliability in surgical care. He has served in advisory roles to national and international efforts for achieving higher quality and safety including the World Health Organization, the Institute of Medicine, the National Quality Forum, PCORI, amongst others. He has received millions of dollars in grant funding to study quality of care from sources that include the National Institutes of Health, the Centers for Disease Control and Prevention, the American Cancer Society, the Centers of Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, and the Veterans Administration. He has published over 350 peer reviewed manuscripts and has written more than 20 book chapters. He is frequently invited to speak nationally and internationally, and was recognized by Becker’s Hospital Review as one of the top 50 experts leading the field of patient safety.
Current national initiatives for Dr. Ko include overseeing the writing of the ACS Quality Manual, implementation of surgical bundles into 1000+ hospitals, and development of a geriatric surgery quality program.
Clinically, Dr. Ko is a double board-certified surgeon with a practice currently focusing on patients with colorectal cancer. At UCLA, he is the Robert and Kelly Day Professor of Surgery, has won the Faculty Teaching Award three times, and is recognized as one of the Best Doctors in America. He is also professor of health services at the UCLA School of Public Health.
Dr. Ko received his B.A (Biology), M.S. (Biological/Medical Ethics), and M.D. from the University of Chicago. He also received a Masters of Science Degree (Health Services/Outcomes Research) from the University of California, Los Angeles during his time as a Robert Wood Johnson Clinical Scholars Fellow at UCLA and RAND. Dr. Ko completed his General Surgery Residency at UCLA Medical Center, and obtained specialty training at the Lahey Clinic in Boston in Colon and Rectal Surgery.